Avid Radiopharmaceuticals Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$896M
Avid Radiopharmaceuticals General Information
Description
Developer of molecular imaging compounds intended for detecting and monitoring chronic human diseases. The company offers Amyvid, an imaging tool for positron emission tomography imaging of beta-amyloid plaque in the brain.
Contact Information
Website
www.avidrp.comCorporate Office
- 3711 Market Street
- Seventh Floor
- Philadelphia, PA 19104
- United States
Corporate Office
- 3711 Market Street
- Seventh Floor
- Philadelphia, PA 19104
- United States
Avid Radiopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 20-Dec-2010 | $896M | Completed | Generating Revenue | ||
| 6. Later Stage VC (Series D2) | 21-May-2009 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 09-May-2007 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 05-Jan-2006 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 14-Dec-2005 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 02-Dec-2005 | $3.9M | $4.4M | Completed | Product Development | |
| 1. Seed Round | 05-Aug-2005 | $500K | $500K | Completed | Startup |
Avid Radiopharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D2 | ||||||||
| Series D1 | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 1,448,473 | $0.001000 | 10% | $3.46 | $3.46 | 1x | $3.46 | 5.49% |
| Series A | 2,673,073 | $0.001000 | 10% | $1.46 | $1.46 | 1x | $1.46 | 10.13% |
Avid Radiopharmaceuticals Patents
Avid Radiopharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2016065145-A2 | Psma targeted reversed carbamates and methods of use thereof | Inactive | 22-Oct-2014 | ||
| WO-2016065145-A3 | Psma targeted reversed carbamates and methods of use thereof | Inactive | 22-Oct-2014 | ||
| US-20120251448-A1 | Compounds for use in the detection of neurodegenerative diseases | Inactive | 03-Mar-2011 | ||
| JP-2012514007-A | Synthesis of 18f-radiolabeled styrylpyridine and its stable pharmaceutical composition from tosylate precursor | Active | 31-Dec-2008 | ||
| JP-5717650-B2 | Synthesis of 18f-radiolabeled styrylpyridine and its stable pharmaceutical composition from tosylate precursor | Active | 31-Dec-2008 | A61K51/0455 |
Avid Radiopharmaceuticals Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AllianceBernstein | Asset Manager | Minority | ||
| Alta Partners | Venture Capital | Minority | ||
| BioAdvance Capital (Conshohocken) | Venture Capital | Minority | ||
| Lilly Ventures | Corporate Venture Capital | Minority | ||
| Osage University Partners | Venture Capital | Minority |
Avid Radiopharmaceuticals FAQs
-
When was Avid Radiopharmaceuticals founded?
Avid Radiopharmaceuticals was founded in 2004.
-
Where is Avid Radiopharmaceuticals headquartered?
Avid Radiopharmaceuticals is headquartered in Philadelphia, PA.
-
What industry is Avid Radiopharmaceuticals in?
Avid Radiopharmaceuticals’s primary industry is Discovery Tools (Healthcare).
-
Is Avid Radiopharmaceuticals a private or public company?
Avid Radiopharmaceuticals is a Private company.
-
What is the current valuation of Avid Radiopharmaceuticals?
The current valuation of Avid Radiopharmaceuticals is .
-
What is Avid Radiopharmaceuticals’s current revenue?
The current revenue for Avid Radiopharmaceuticals is .
-
How much funding has Avid Radiopharmaceuticals raised over time?
Avid Radiopharmaceuticals has raised $72.5M.
-
Who are Avid Radiopharmaceuticals’s investors?
AllianceBernstein, Alta Partners, BioAdvance Capital (Conshohocken), Lilly Ventures, and Osage University Partners are 5 of 8 investors who have invested in Avid Radiopharmaceuticals.
-
When was Avid Radiopharmaceuticals acquired?
Avid Radiopharmaceuticals was acquired on 20-Dec-2010.
-
Who acquired Avid Radiopharmaceuticals?
Avid Radiopharmaceuticals was acquired by Lilly USA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process